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Abstract
Objectives—To examine the acceptability and initial efficacy of an emotional self-awareness 
treatment at reducing alexithymia and emotion dysregulation in participants with traumatic brain 
injury (TBI).
Setting—Outpatient rehabilitation hospital.
Participants—Seventeen adults with moderate to severe TBI and alexithymia. Time post-injury 
ranged 1–33 years.
Design—Within subject design, with 3 assessment times: baseline, posttest, and 2-month follow-
up.
Intervention—Eight lessons incorporated psycho-educational information and skill-building 
exercises teaching emotional vocabulary, labeling and differentiating self-emotions; interoceptive 
awareness; and distinguishing emotions from thoughts, actions and sensations.
Measures—Alexithymia (TAS-20); Emotional Awareness (LEAS); Trait Anxiety (TAI); 
Depression (PHQ-9); Anger (STAXI); Emotion Dysregulation (DERS); and Positive and Negative 
affect (PANAS).
Results—Thirteen participants completed the treatment. Repeated measures ANOVA revealed 
changes on the TAS-20 (p=.003), LEAS (p<.001), TAI (p=.014), STAXI (p=.015), DERS (p=.020) 
and Positive Affect (p<.005). Paired t-tests indicated significant baseline to posttest improvements 
Correspondence to: Dawn Neumann.
Reprint requests to Dawn Neumann, PhD
HHS Public Access
Author manuscript
J Head Trauma Rehabil. Author manuscript; available in PMC 2018 September 01.
Published in final edited form as:
J Head Trauma Rehabil. 2017 ; 32(5): 286–295. doi:10.1097/HTR.0000000000000277.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
on these measures. Gains were maintained at follow-up for the TAS, LEAS, and Positive Affect. 
Treatment satisfaction was high.
Conclusion—This is the first study published on treating alexithymia post-TBI. Positive changes 
were identified for emotional self-awareness and emotion regulation; some changes were 
maintained several months post-treatment. Findings justify advancing to the next investigational 
phase for this novel intervention.
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INTRODUCTION
Anxiety, depression, anger and overall emotion dysregulation are common after traumatic 
brain injury (TBI).1–4 These emotional impairments are often challenging to treat and 
ultimately become chronic problems for many survivors of TBI. These emotional sequelae 
typically have an adverse impact on psychosocial functioning, relationships, community re-
integration, and quality of life.5–9
After a TBI, it is not unusual to have problems processing emotions.10 Of particular interest 
here are emotion-processing deficits characteristic of a psychological construct referred to as 
alexithymia. Quintessential features of alexithymia are poor awareness for personal 
emotions; reduced acknowledgement of physical sensations and association with emotional 
responses (e.g., elevated heart rate and fear); difficulty describing and/or trouble 
distinguishing emotions (e.g., differentiating anger from sad); and a preference for 
discussing concrete or superficial facts rather than emotions.11 The prevalence of 
alexithymia after TBI ranges from 30–61%10,12,13 compared to 10%14 in the non-TBI 
population. Since alexithymia has been associated with emotion dysregulation deficits after 
TBI, such as anxiety, depression, and anger,13,15–17 it is a deficit that warrants considerable 
attention and concern.
There are several theoretical assumptions regarding the association of alexithymia with 
emotion dysregulation. One assumption is that emotional awareness is needed to consciously 
regulate emotions.17 Also, reduced awareness and difficulty describing emotions has been 
associated with avoidant coping skills.13 If one avoids a problem that causes emotional 
distress, that problem is likely to remain unresolved and may compound and/ or surface 
through behavior. Furthermore, neuroimaging research suggests that the cognitive process of 
labeling emotions helps down regulate the emotional limbic reaction18–21; therefore people 
who have trouble describing their emotions may have difficulty regulating unpleasant 
feelings.
There are currently no evidence-based, standard treatment approaches for reducing 
alexithymia after TBI. To date, there have been two publications examining a treatment 
specifically designed for alexithymia; neither of which were in the TBI population. One 
study involved thirteen otherwise normal male participants with alexithymia (likely the 
result of poor developmental socialization).22 Participants were taught an emotional 
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vocabulary and to use an emotional diary to describe their feelings. Problems with 
alexithymia were significantly less after treatment. There was also a case study of a patient 
who had alexithymia after a stroke. This patient was similarly taught an emotional 
vocabulary, and in addition, video-feedback and heart rate biofeedback were used to enhance 
the patient’s awareness for his own emotional responses.23 This patient showed substantial 
reductions in alexithymia, suggesting that alexithymia may be minimized after brain damage 
with such targeted treatment.
Given the prevalence of alexithymia after TBI and associated negative outcomes, we 
developed a treatment to target characteristics of alexithymia in people with TBI. In 
adherence with recommendations for a phased developmental approach towards 
rehabilitation studies, which encourages appropriate preliminary studies before proceeding 
to randomized controlled trials, this study was designed as a Phase I trial to examine proof-
of-concept and feasibility of this novel intervention.24 Therefore one aim was to examine 
initial efficacy on primary and secondary outcomes through changes in effect sizes. Primary 
outcomes were alexithymia and emotional awareness, while secondary outcomes pertained 
to emotion regulation variables (i.e., anxiety, depression, anger, positive and negative affect, 
and general emotion dysregulation). With respect to feasibility, we were particularly 
interested in participant acceptability (satisfaction) with the program. A within subject 
design with three assessment periods was used: baseline, immediate post-test and two-month 
follow-up. We hypothesized moderate to large effect sizes on our alexithymia and emotional 
awareness measures since we were explicitly teaching these skills. We had several 
hypotheses regarding the potential outcomes on emotion regulation. Based on the theories 
described above regarding the association of alexithymia with emotion dysregulation, one 
might expect that teaching emotional awareness and labeling skills would position 
participants to better regulate their emotions. Therefore, one hypothesis was that we would 
observe significant improvements in anxiety, depression, anger, affect, and overall emotion 
dysregulation. In contrast, it is possible that training emotional awareness and labeling 
would not generalize to emotion regulation because teaching emotional control was not part 
of treatment. Also, poor emotion regulation was not an inclusion criterion and therefore may 
not have been a problem for some participants. Another possibility is that changing behavior 
(emotion regulation) takes time and might not appear until follow-up. Alternatively, the 
immediate effect of newfound emotional self-awareness might be overwhelming and 
unpleasant for some individuals, and therefore result in an initial increase in anxiety, 
depression, or overall negative affect.
METHODS
Participants
When the goal of a study is to estimate initial effect sizes for the purposes of designing a 
larger trial, statistical guidelines recommend using a sample size of 12 for a pre-post 
design.25 In anticipation of a possible 20% drop-out rate we aimed to enroll a minimum of 
15 participants. Recruitment letters were sent to current and former patients of a local 
rehabilitation hospital. Also, flyers were posted in the hospital’s outpatient clinic and were 
disseminated at local brain injury support groups. Recruitment materials specified that we 
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were looking for people who had had a moderate to severe TBI to participate in an 
investigational treatment study on emotional problems after brain injury. Many participants 
who were interested in the study initiated contacting us directly after receiving a recruitment 
letter or flyer; we also followed-up recruitment letters with a phone call. Ultimately, we 
made phone contact with 72 people; 57% declined participation for the following reasons: 
not interested (44%); too busy (16%); felt they did not have emotional problems/ need 
treatment (15%); had transportation challenges (15%); or had communication problems that 
would prohibit their participation (10%). Those who expressed interest in the study (n=31) 
were prescreened; 25 participants passed prescreening criteria, of which seventeen met the 
full study criteria and were enrolled into treatment.
Eligible participants had sustained a moderate to severe TBI, as defined by at least one of the 
criteria outlined by the Mayo classification system for TBI26: Glasgow Coma Scale score 
<13 (at the time of injury), post-traumatic amnesia ≥24 hours, loss of consciousness ≥30 
minutes, or abnormal neuroimaging results consistent with moderate to severe brain injury. 
Participants were between 18 and 75 years old and were a minimum of one-year post-TBI. 
Consistent with inclusion criteria, eligible participants had moderate to severe alexithymia 
(≥52 on the Toronto Alexithymia Scale-20 determined at screening). Participants were 
allowed to continue medications and ongoing therapies. They were excluded if they had a 
pre-morbid acquired brain injury (e.g. stroke), neurological disorder (e.g. autism), or a major 
psychiatric disorder (e.g. schizophrenia) other than depression or posttraumatic stress 
disorder (PTSD). Since depression and PTSD are so common after TBI and strongly 
correlated with alexithymia, we did not exclude patients with these conditions in order to 
achieve a more representative sample. See Table 1 for details regarding participant 
demographics and relevant medical history.
Primary Measures
Toronto Alexithymia Scale (TAS-20)11,27—This self-report questionnaire measures 
total alexithymia, and three subconstructs: difficulty identifying feelings (awareness), 
difficulty describing feelings, and externally-oriented thinking. Scores range from 20–100; 
≥52 indicates moderate alexithymia, and ≥61indicates high alexithymia. Participants had to 
score a ≥52 for treatment eligibility. The TAS-20 has been used in the TBI 
population10–13,15,17, and is reported to have good internal consistency, validity, and test-
retest reliability.11,27
Levels of Emotional Awareness Scale (LEAS)28—The LEAS is a performance-based 
measure of emotional awareness and vocabulary. In response to 10 hypothetical scenarios, 
participants must say how they think they and a character in the scenario would feel. 
Responses were open-ended and later entered into a computerized scoring system.29 Scores 
range from 0–50, with higher scores indicating better emotional awareness and vocabulary. 
The LEAS consists of parellel versions (A and B). This test has been used in people with 
TBI.30 The LEAS has significantly correlated with other measures of emotion perception 
and has good reliability indicators.28,31
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Secondary Measures
State Trait Anxiety Inventory (STAI)32—This self-report measure has a State Anxiety 
scale, which inquires about feelings in that moment, and Trait Anxiety scale which asks 
about general feelings over time. Scores range from 20–80 for each subscale. Higher scores 
indicate greater anxiety. Age and gender norms were used to convert raw scores to standard 
scores. For the purposes of this study, we only report trait anxiety scores. The STAI has been 
shown to have concurrent validity with other anxiety measures.33
Patient Health Questionnaire (PHQ-9)34—The PHQ-9 is a self-report assessment of 
depression with a Likert scale ranging from 0–3 (max score 27). Participants rate the 
frequency of specified problems during the past two weeks. The PHQ-9 has established 
validity and reliability.35,36
State Trait Anger Expression Inventory-2 (STAX-2I)—This self-report assessment 
uses a 4-point Likert scale to measure three constructs: 1) state anger; 2) trait anger; and 3) 
behaviors and reactions when angry. Scores from these constructs are used to calculate an 
Anger Index T score (using age and gender norms), which provides an overall estimate of 
the person’s likelihood to express anger outwardly or inwardly. The STAXI-2 has been 
shown to have good internal consistency.37,38
Positive and Negative Affect Scale (PANAS)39—Using a 5-point scale, participants 
rate the extent to which they have experienced 10 positive mood states (Positive Affect) and 
10 negative mood states (Negative Affect) during a specified time frame. The measure has 
shown good reliability and validity in a variety of populations. The scales are shown to be 
internally consistent and stable over several weeks.39,40
Difficulty with Emotion Regulation Scale (DERS)41—Using a 5-piont Likert Scale, 
participants rate the frequency they utilize specific emotion regulation behaviors. There are 
six scales: Lack of Emotional Awareness, Lack of Emotional Clarity, Difficulties 
Controlling Impulsive Behaviors when Distressed, Difficulties Engaging in Goal-Directed 
Behavior When Distressed, Nonacceptance of Negative Emotional Responses, and Limited 
Access to Effective Emotion Regulation Strategies. Items are summed to provide a Total 
Emotion Dysregulation score. The DERS has high internal consistency test-retest reliability, 
and good construct validity.41
Satisfaction Questionnaires—Satisfaction questions were created by the authors and 
administered at post-test and follow-up. Questions were designed to evaluate overall 
satisfaction; perceived relevance to their needs; implementation of strategies to their daily 
life; clarity of information; translation to emotion regulation and quality of life. See Table 4 
for questions and responses.
Intervention
The intervention was comprised of eight sessions involving psycho-educational lessons and 
skill-building exercises to accomplish the following goals: understand the benefits of 
emotional awareness; enhance emotional vocabulary; improve accuracy for describing 
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personal emotions; acknowledge and differentiate multiple emotions; increase awareness for 
emotional responses, including changes in physical sensations; and distinguish emotions 
from thoughts, actions and physical sensations. These objectives were chosen based on the 
aforementioned characteristics typically associated with alexithymia. A clinical research 
assistant (RA) delivered the treatment, which was comprised of lessons that were presented 
on a computer through a 3rd party learning management system, Lesson.ly. The standardized 
treatment content was outlined on the computer and closely followed by the clinical RA. In 
order to make the sessions more engaging and natural, the treatment content was not read 
verbatim; the RA was given the liberty to paraphrase the content. The psycho-educational 
content was to be used as a guideline for points of discussion; the RA was instructed to 
address all of these points with the participant as part of their sessions. Elaborated 
discussions between the RA and participant were encouraged and focused on personalizing 
the content (i.e. examine how the content applied to them). The RA had the liberty to 
determine which content needed more or less discussion based on the participants’ 
performance on the session exercises.
The first four lessons focused on teaching the principles underlying the key objectives, 
followed by interactive discussions and practice exercises. Lessons five through eight were 
exercises that used first-person perspective videos simulating emotional scenarios to give 
participants the opportunity to practice processing their emotional responses to events (e.g. 
getting yelled at by a boss in front of colleagues). See Table 2. An Emotional Compass was 
used throughout training to guide participants’ discovery of their emotions by leading them 
from vague emotional descriptors (e.g bad) to more specific emotions (e.g. worried). The 
compass delineates emotions by valence (pleasant and unpleasant) and emotional arousal 
(high and low). Participants were given a notebook with the lessons, and take home 
exercises for each session. Take home lessons encouraged participants to personalize and 
incorporate the lessons into their daily life and to discuss what they learned with their family 
members.
Procedures
This study was registered on clinicaltrials.gov (NCT02432300) and approved by the 
Institutional Review Board. Interested participants were prescreened on the telephone; those 
who met initial screening criteria were scheduled for baseline testing. All participants 
provided consent prior to baseline testing. At each testing point, the Research Assistant (RA) 
read the questions from the assessments to participants and hand-recorded their responses. 
Responses to the LEAS were written and audio recorded for later verification of the 
subjects’ responses. LEAS versions A and B were alternated between assessment time 
points. To minimize potential bias, the RA who conducted the participant’s post-testing was 
always different from the RA who conducted that person’s baseline testing. The “clinical 
RA” who was responsible for treatment administration never tested participants.
Baseline Testing, Post-test and Follow-up Testing—Following consent, baseline 
testing involved a demographics and medical history questionnaire, followed by the TAS-20, 
LEAS, PHQ-9, TAI, PANAS, DERS, and STAXI-2. Participants who scored ≥52 on the 
TAS-20 at baseline were enrolled into treatment. Post-testing occurred within one week of 
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finishing the training program. Follow-up testing aimed to assess participants approximately 
2-months after posttest; however due to scheduling conflicts some follow-up testing 
occurred closer to three and four months later (mean 80.46; range 57–127 days). Baseline 
and post-testing always occurred in-person at the rehabilitation hospital, with the exception 
of the final assessments, which could be performed by telephone in order to minimize 
chances for lost to follow-up; two participants selected this option. Post-testing and follow-
up testing involved all of the same assessments as baseline, minus the demographics and 
medical history form, and with the addition of the satisfaction questionnaire. Participants 
were also asked at post-test and follow-up about receipt of psychological counseling and any 
changes in medication.
Intervention—The clinical RA delivering the treatment was a 4th year doctoral psychology 
student who had experience working with the TBI population. He was trained for 16 hours 
on treatment delivery, followed by 16 hours of observation and feedback. Sessions lasted 
between 60–90 minutes and were delivered individually to participants twice a week for 4 
weeks. Treatment content was displayed on a computer in order to standardize the 
information to be covered. The material guided an interactive discussion between the clinical 
RA and participant. Participants completed skill-building exercises and quizzes on the 
computer. Visual aids were used to illustrate certain points.
Data Analyses
Descriptive statistics were calculated for participant characteristics, injury related variables, 
and all outcome variables. Associations of alexithymia with participant characteristics and 
injury related variables were examined with Pearson correlations. Changes on outcome 
measures were calculated with repeated measures ANOVA. Greenhouse-Geisser was used to 
determine significance of within subjects effects when Maulchy’s Test of Sphericity was 
violated. When repeated measures of ANOVA were found significant, planned comparisons 
were calculated using paired t-tests to evaluate changes from Time 1(baseline) to Time 2 
(posttest) and Time 1-Time 3 (2 month follow-up). The alpha level for these comparisons 
was adjusted for two comparisons (α=.025). The percent of participants who changed in 
level of severity on the TAS over the course of treatment is reported. Since the other primary 
outcome measure (LEAS) does not have normative data regarding categorical impairment 
levels like the TAS, we report the percent of participants who obtained at least a ½ standard 
deviation change (effect size of .5). This level of change is considered to be a reasonable 
estimation of the Minimal Clinically Important Difference (MCID) for a measure in the 
absence of more definitive determination of the MCID.42 Because a primary goal of the 
study was to determine effect sizes, dCohen effect sizes were calculated for all variables 
from Time 1-Time 2 and Time 1-Time 3 (.2=small; .5=medium and .8=large effect sizes).43
RESULTS
Participants
Of the 17 participants who were eligible and enrolled into the treatment, 13 participants 
completed the treatment, resulting in a 23.5% dropout rate. One person reported the day 
after his first session that he did not like the program, even though he indicated high 
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satisfaction on the session satisfaction questionnaire; two said they could no longer do it 
(one after 5 sessions and the other after 1, despite positive feedback on their session 
satisfaction questionnaires); and the fourth participant had unrelated medical complications 
that interfered with study participation after his second session. There was a100% retention 
rate at post-test and follow-up for the participants who completed the treatment.
Between baseline and pretest, three participants continued to receive ongoing psychological 
counseling (1 to 3 sessions) which had been initiated prior to enrollment; however, 
according to these participants the sessions did not focus on improving emotional awareness. 
In terms of medication changes, one participant started an antibiotic. Between post-test and 
follow-up, five participants continued to receive ongoing psychological counseling which 
had been initiated prior to enrollment; for three of these participants, sessions did address 
emotional awareness to some degree. Three participants changed medication between post-
test and follow-up; one went off an anti-depressant; one changed antidepressants from 
tricyclic antidepressant amitriptyline to serotonin reuptake inhibitor sertraline; and one 
started a pain medication.
Correlations calculated on the 17 enrolled participants showed no significant associations of 
alexithymia with sex, age, and years of education, years post-injury, self-reported duration of 
post-traumatic amnesia, or loss of consciousness duration (p>.05).
Post-treatment Changes on Primary Outcome Measures
Repeated measures of ANOVA showed significant improvements on the TAS-20 
(alexithymia) and the LEAS (emotional awareness) over time. Additional t-tests revealed 
that post-test and follow-up scores for both measures were significantly improved from 
baseline scores, even after adjusting for multiple comparisons (α=.025). Eight (62%) 
participants changed to a less severe alexithymia category on the TAS-20 at post-test, of 
which 6 were lowered to normal (<52); five of the six remained in the normal category at 2-
month follow-up. Findings also revealed that 46.2% of participants improved by >.5 SD at 
posttest on the LEAS (≥6) and 61.5% showed this degree of improvement at 2-month 
follow-up. See Table 3.
Post-treatment Changes on Secondary Outcome Measures
Findings from the repeated measures of ANOVA showed significant improvements on the 
TAI (anxiety), STAXI (anger), Positive Affect, and DERS (emotion dysregulation) over 
time. Scores on the PHQ-9 (depression) and the Negative Affect measures did not change 
significantly. Greenhouse-Geisser was used to determine within subject effects for the TAI 
and Negative Affect. Posttest scores were significantly better than baseline for the TAI, 
STAXI, Positive Affect, and the DERS; after adjusting for multiple comparisons (α=.025), 
all differences remained significant except the STAXI (p=.027). Two-month follow-up 
scores were significantly better than baseline for the TAI and Positive Affect; after adjusting 
for multiple comparisons the TAI was no longer significant (p=.038). See Table 3.
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Treatment Satisfaction
Descriptive statistics were calculated for treatment satisfaction at posttest and the 2-month 
follow-up. Results indicate participants were largely satisfied with the treatment and felt the 
treatment helped them. See Table 4.
DISCUSSION
Alexithymia and commonly related emotion dysregulation deficits are quite prevalent after 
TBI.1–4,10,12,13 While a few emotion regulation treatment studies in the TBI population have 
incorporated some emotional self-awareness training, it has typically been a small part of a 
holistic approach and changes in alexithymia were not evaluated.44–48 Consequently, this is 
the first study to examine proof of concept for a treatment that focused primarily on 
improving components of alexithymia (e.g. emotional awareness, labeling, interoceptive 
awareness) in people with TBI.
Participants’ emotional self-awareness and ability to describe and differentiate emotions 
were significantly improved immediately after treatment, and 2-months later. This suggests 
the benefits were maintained over time. As hypothesized, effect sizes for the TAS and LEAS 
were quite large at posttest, and medium-to-large 2-months later. Furthermore, 62% of 
participants reduced the categorical severity of their alexithymia, with 6 participants 
changing to “low” (normal) alexithymia at post-test, of which five remained in that category 
2-months after treatment ended. Almost half (46.2%) of the participants had a clinically 
meaningful improvement on the LEAS.
Another goal of the study was to examine changes in emotion dysregulation post-treatment. 
Despite not being explicitly trained to regulate unpleasant emotions as part of this 
intervention, initial improvements were found for anxiety, positive affect, and overall 
emotion dysregulation, and there was a trend towards a reduction in anger. Two months post-
treatment, significant improvements were maintained for positive affect, and a maintenance 
trend emerged for anxiety. Although some findings were no longer significant after 
correcting for multiple comparisons, it should be recalled that effect sizes, not statistical p 
values, were the primary concern for this phase I trial. Effect sizes immediately after 
treatment ranged from medium to large for alexithymia, emotional awareness, positive 
affect, anxiety, and overall emotion regulation (DERS); effect sizes were small for anger. 
Two months later, positive affect and anxiety effect sizes were still large and medium, 
respectively. Depression and negative affect did not change significantly at either time point. 
It is possible that scores on the PHQ-9 did not change substantially because items such as 
fatigue, sleep, and concentration, may not have actually been indicative of depression, but 
rather mere effects of the TBI that would not expect to be impacted by this treatment; 
potentially another measure of depression may have been more appropriate. However, 
another possibility is that the treatment had different effects on depression in different 
individuals. Upon closer inspection of the PHQ-9 scores, it appears depression increased for 
some and decreased for others, averaging to no change. It is possible that increased 
emotional self-awareness initially resulted in more depression for some individuals, 
suggesting depression should be monitored during this type of treatment.
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When comparing the treatment effects on our primary and secondary outcomes, the 
distinction between emotional self-awareness and emotion regulation becomes apparent: we 
observed large immediate and long-term effects for the former, and a few shorter-lived 
changes for the latter. These preliminary findings suggest that improving emotional 
awareness and labeling can partially help people to better control some unpleasant emotions, 
however, it is not sufficient on its own to make a robust and lasting effect. This supports the 
notion that this type of training should be considered as a precursor or supplement to other 
techniques that explicitly teach patients how to regulate their emotions. Future work should 
further investigate the degree of impact that training emotional awareness has on emotion 
regulation, and to what degree emotion regulation needs to be specifically targeted.
Determining consumer acceptability of interventions is an important component of phase I 
clinical testing. Responses to post-treatment satisfaction questions, as seen in Table 4, 
indicate that the 13 participants who completed the treatment were quite satisfied with the 
program. Ultimately four people withdrew from treatment; however, only one person 
withdrew from the program because he was dissatisfied with the treatment. The remaining 
three who withdrew from the program showed high satisfaction on their session satisfaction 
ratings. Unfortunately, one participant was unable to complete the program due to unrelated 
medical complications. The other two participants did not elaborate on their reasoning for 
withdrawing beyond saying they could no longer do it; however, both claimed their decision 
to withdraw was unrelated to the program. Future studies with ample sample size should 
continue to explore dropout rates and reasoning for withdraw in order to better understand 
consumer acceptance of this intervention.
Limitations
The lack of a control group, and not controlling for some potentially confounding variables 
(medication and outside counseling) clearly prevents us from making any cause-effect 
inferences about the treatment on the outcomes. It is possible that spending time with our 
clinical RA could have had an impact on participants’ anxiety, positive affect, and overall 
emotion regulation. With respect to other counseling, their outside sessions during the 
alexithymia intervention did not focus on emotional awareness (according to the 
participants), and therefore unlikely the reason for their improvement on the TAS and LEAS 
at posttest. Further, the fact that the outside sessions were a stable part of these participants’ 
routines pre-study, combined with the low number of sessions between baseline and post-
test, also reduce the likelihood they played a significant role in post-test changes.
The small sample size, while adequate to determine effect size, reduces generalization of 
these results to the larger TBI population. Small sample sizes and within subject designs are 
considered appropriate for the exploratory stage of this novel intervention. This was a 
critical stepping-stone, justifying the time and money needed to execute a larger, more 
definitive study to determine the effectiveness of this novel treatment for alexithymia in the 
TBI population. Until an adequately powered RCT substantiates these results, current 
findings should be viewed with caution.
Another study limitation is that most measures were subjective, and due to the nature of 
being alexithymic (poor emotional awareness), there may be some concern about their 
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accuracy on the subjective emotional measures. However, it is important to note that even 
though people with alexithymia may not always be aware of their emotions in the moment, 
they are often able to acknowledge general emotional deficits. Most are generally aware they 
have problems with their own emotional awareness (an indicator which qualified them for 
the study), and are capable of acknowledging symptoms of anxiety, depression and anger as 
they are described on these measures. That said, having input from caregivers or possibly 
some objective assessments for behavioral changes would have strengthened the study. 
However, if participants feel that they had fewer or less severe emotional problems after the 
treatment, this positive change in self-perception is also meaningful. Moreover, a change on 
the performance-based LEAS was an objective indicator of improved emotional awareness. 
Since alternate forms were used for the LEAS, it is unlikely these changes were due to a 
learning effect.
CONCLUSION
This is the first study to collectively examine post-treatment changes in alexithymia and 
emotion dysregulation in people with TBI. Post-treatment changes indicated moderate to 
large effects sizes, with improvements in alexithymia, emotional awareness, anxiety, positive 
affect and overall emotion regulation. Some of these changes were maintained over two 
months. These preliminary findings are encouraging, especially since the treatment was only 
eight sessions and participants were many years post-injury (average almost 9 years). 
However, further investigation is needed to have a more definitive understanding of the 
treatment effect. These promising results support the next phase of investigation involving a 
larger controlled study. If validated through a controlled study, this training program has the 
potential to have a substantial impact on the way emotion dysreguation deficits are treated 
after TBI. It is anticipated that this type of intervention would not be administered in 
isolation. If it is found that this treatment can help people with TBI effectively recognize and 
describe their emotions, additional studies should evaluate the benefit of adding it as a 
precursor to treatments that explicitly teach modification of unpleasant emotional responses 
(e.g CBT), to achieve a more robust effect on both emotion awareness and regulation.
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Table 1
Demographic and medical history. N=17 unless otherwise specified.
Participants enrolled in treatment (n=17)
Mean (S.D.) or % (raw)
Age 46.12 (11.41)
Sex (% male) 76.5% (13)
Education (years) 14.06 (2.36)
Race
%White 94.1% (16)
% Other 5.9% (1)
Cause of Injury
Motor Vehicle Accident 44% (8)
Fall 32% (5)
Assault 8% (1)
Other 16% (3)
Years post-injury 8.73 (8.10)
PTA (days) 95.35 (187.45)
Loss of Consciousness (days) 14.18 (25.39)
Abnormal neuroimaging (n=13)
% Cerebral Contusion 23% (3)
% Hematoma 46% (6)
% Post-traumatic Hemorrhage 77% (10)
J Head Trauma Rehabil. Author manuscript; available in PMC 2018 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Neumann et al. Page 16
Table 2
Intervention Components. All sessions (aside from session 1) started with a review of take home exercises and 
ended with assigning the next take home exercise.
Lesson Activity
Lesson 1: • Benefits of emotional awareness: better emotional control, better relationships, coping, quality of life, decision-
making
• Emotional responses: Triggers, sensations, emotions; and behavior
• Definition ofalexithymia
• Emotional vocabulary Part I: vague emotions versus specific emotions; presentation of some common emotions, 
their definitions, and synonyms that participants are asked to use in sentences.
Lesson 2: • Review of Emotional vocabulary Part I
• Emotional vocabulary Part II: presentation of more common emotions, their definitions, and synonyms that 
participants are asked to use in sentences.
• Differentiating emotions from thoughts, actions and physical sensations.
Lesson 3: • Physical sensation awareness, emotional arousal, and association to emotions (Part I);Exercises to increase 
awareness of heart rate, body temperature, breathing, body movement and overall emotional arousal (e.g. Body 
scan)
Lesson 4: • Physical sensation awareness and association to emotions (Part II)
• Multiple emotions, differentiating emotions, and emotions beyond anger
Lessons 5–8 Simulated first person point of view emotional scenarios, followed by discussions of
thoughts, desired actions, physical sensations, and emotional responses in response to
the scenarios. Afterwards, participants described similar personal events and their
emotions, thoughts, actions and feelings response.
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Table 3
Descriptive Statistics, Repeated Meaures ANOVA and Paired test results, and effects sizes.
Baseline
(T1)
Mean
(S.D.)
Post-
test
(T2)
Mean
(S.D.)
Follow-up
(T3)
Mean
(S.D.)
Repeated Measures ANOVA
(partial eta squared)
Paired t-tests
(dCohen Effect Size)
TAS-20
(Alexithymia)
61.54
(7.26)
52.54
(11.95)
54.62
(12.38)
F=7.688, p=.003 (.390)
T1–T2: t=3.527, p=.004 (−1.240)*
T1–T3: t=2.688, p=.020 (−.953)*
LEAS
(Emotional
Awareness)
36.92
(7.88)
44.23
(5.23)
42.23
(8.29)
F=11.76, p<.001 (.495)
T1–T2: t=−4.766, p<.001.(.928)*
T1–T3: t=−2.894, p=.013 (.674)*
PHQ-9
(Depression)
10.77
(4.82)
9.69
(5.25)
10.31
(5.89)
F=.411, p=.668 (.033)
T1–T2: (−.224)
T1–T3: (−.095)
TAI (Trait
Anxiety t-score)
68.38
(11.45)
61.54
(12.08)
62 (15.15) F=6.640, p=.014 (.356)
T1–T2: t=3.715, p=.003 (−.597)*
T1–T3: t=2.336, p=.038 (−.557)
STAXI Index t-
score (anger)
56.31
(11.40)
52.31
(10.42)
56.46
(11.11)
F=4.995, p=.015 (.294)
T1–T2: t=2.523, p=.027 (−.351)
T1–T3: t=−.099, p= .923 (.013)
Positive Affect 25.85
(6.49)
31.77
(8.96)
31 (10.08) F=6.655, p=.005 (.357)
T1–T2: t=−3.211, p=.007 (.924)*
T1–T3: t=−3.022, p=.011 (.803)*
Negative Affect 23.23
(7.6)
19.69
(7.34)
19.85
(7.22)
F=2.674, p=.121 (.182)
T1–T2: (−.466)
T1–T3: (−.445)
DERS (Emotion
Dysregulation)
97.77
(21.43)
84.08
(25.36)
87.31
(24.33)
F=4.601, p=.020 (.277)
T1–T2: t=2.618, p=.022 (−.639)*
T1–T3: t=2.171, p=.051 (−.488)
*
Indicates differences that remained significant after adjusting for multiple comparisons.
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Table 4
Satisfaction Questions and Responses
Post-test Satisfaction Questions (5-point Liker scale to rate their level of
agreement (1=Strongly Disagree; 2=Disagree; 3=Neutral; 4=Agree;
5=Strongly Agree)
Mean (S.D.)
% Agreed/ Strongly
agreed
(N=13)
I am satisfied with the information in this training program 4.62 (.506)100%
The lessons taught in the training are relevant to my needs 4.62 (.650) 92.3%
I will try to use lessons I learned in my daily life 4.69 (.630) 92.3%
The information provided was easy to understand 4.08 (.760) 77%
If a friend or family member was in need of similar help, I would
recommend the program to him or her
4.62 (.506) 100%
I think the training program has helped me to deal more effectively with
my emotions
4.38 (.768) 85%
Follow-up Satisfaction Questions Mean (S.D.)
How often would you say you have used the skills you were taught in the
training program in the last several months (1=Never; 2=Not often;
3=Often; 4=Very often)
3.15 (.689)
85% often or very often
Generally speaking, how much do you think the training program has
helped you in the last several months? (1=Did not help; 2=helped a little;
3=moderately helpful; 4=helped a lot)
3.00 (.707)
77% moderately
helpful to helped a lot
Since the training, I feel my quality of life has improved as a result of the
information I learned in this program. (1=Strongly Disagree; 2=Disagree;
3=Neutral; 4=Agree; 5=Strongly Agree)
4.08 (.641)
85% agreed or strongly
agreed
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